What the clinical trials actually found Six randomized, double-blind, placebo-controlled trials involving over 900 participants have evaluated AOD 9604 in humans
Both pills and injections have excellent safety profiles
When administering a higher dose, the benefits should be weighed against the risks
Neurological manifestations are particularly concerning and may include peripheral neuropathy with paresthesias (tingling and numbness in hands and feet), ataxia, impaired proprioception and vibratory sense, cognitive impairment, memory loss, and in severe cases, subacute combined degeneration of the spinal cord
Some prefer mixing in the same syringe for fewer injections, while others administer separately to allow individual tracking